Skin whitening and pigmentation reduction

Query for «skin whitening», «complexion lightening» or hyperpigmentation control through IV glutathione, vitamin C injections and similar protocols. FDA Philippines and AEMPS publicly warn that IV glutathione for skin lightening is unapproved and safety is unproven.

1 drug

Also known as: IV skin whitening drips, Glutathione for skin lightening, Anti-melanin therapy

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

FGlutathioneNot recommended · Tripeptide antioxidant (γ-glutamyl-cysteinyl-glycine); cofactor of glutathione S-transferaseIV glutathione drips and injections are heavily marketed for «skin whitening». FDA Philippines issued an official warning in 2019: IV glutathione for skin lightening is not approved by any regulator; fatal cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, renal and hepatic failure have been reported. AEMPS confirmed in 2022 that such products are not registered in Spain and are treated as adulterated. AEDV recommends retinoids, azelaic acid, hydroquinone and picosecond laser treatment for hyperpigmentation, with confirmed efficacy and controlled safety. Before any «whitening» course, consider seeking a dermatologist's second opinion.

How to read tiers A–F

Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.

AStrong evidence – first or second line in international guidelines
BRecommended in selected cases
CStudy data contradict each other
DBenefit not proven, no documented harm
FDocumented harm, or risk without benefit